The White House launched a new cybersecurity safety label, the U.S. Cyber Trust Mark, intended to help consumers make ...

The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

A government watchdog examining the FDA’s accelerated approval pathway has released a 32-page report (PDF) that concludes the agency’s controversial endorsement of Biogen’s failed Alzheimer ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Dalton, GA - November 17 - The Carpet and Rug Institute (CRI) has launched a new Seal of Approval program designed to recognize superior carpet cleaning products that pass stringent tests ...

The authorization does not mean the products are safe or “FDA approved,” however. Perspective from Johannes Thrul, PhD The FDA announced it has authorized the marketing of 20 Zyn nicotine ...

As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for patients with HR-positive, HER2-negative breast cancer. The FDA has approved ...

Ryoncil, the first mesenchymal stromal cell therapy, showed a 70% overall response rate in pediatric steroid-refractory acute GVHD, with a median DOR of 54 days. The FDA approved several drugs in ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo ...

AstraZeneca and Daiichi's first co-developed ADC, Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions. In December ...